DENVER, July 21, 2023 /PRNewswire/ — ViewRay, Inc. (the “Company”) (Nasdaq: VRAY) announced today that on July 17, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”). Nasdaq has determined that due to the Company’s voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code, and … Read more
Cette autorisation de mise sur le marché remplace l’autorisation de mise sur le marché conditionnelle qui avait été accordée au médicament et est la première pour Novavax dans l’Union européenne L’autorisation de mise sur le marché inclut l’utilisation de Nuvaxovid™ en tant que série primaire chez les adolescents âgés de 12 ans et plus et comme rappel chez … Read more
Cyltezo® (adalimumab-adbm) expands treatment options for patients across multiple chronic inflammatory diseases Cyltezo is the only adalimumab biosimilar with Phase III comparative clinical studies in rheumatoid arthritis, plaque psoriasis and Crohn’s disease RIDGEFIELD, Conn., July 1, 2023 /PRNewswire/ — Boehringer Ingelheim announced today that Cyltezo® (adalimumab-adbm), a U.S. Food and Drug Administration (FDA)-approved Interchangeable biosimilar to Humira® … Read more
Conference Call to be Held Today at 4:30pm ET SAN DIEGO, June 28, 2023 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today reported financial results for its fiscal year ended March 31, 2023 and provided an update on recent … Read more
Acquisition of Spyre and concurrent oversubscribed $210 million private investment positions the company to advance a leading inflammatory bowel disease (IBD) portfolio Spyre, the second spinout from Paragon Therapeutics, is advancing a pipeline of product candidates, led by SPY001 and SPY002, that are potentially best-in-class antibodies targeting a4b7 and TL1A, respectively, and which are expected … Read more
MADISON, Conn., June 22, 2023 /PRNewswire/ — Precision X-Ray, Inc. (“Precision”), a pioneer in cabinet X-ray irradiators, proudly announces the launch of our latest technology into Sterile Insect Technique (SIT). This game-changing solution provides unparalleled environmental control within our family of irradiators and champions the cause of non-GMO and environmentally friendly insect control methods. Our cutting-edge … Read more
SAN FRANCISCO, June 22, 2023 /PRNewswire/ — The global population health management market size is expected to reach USD 280.8 billion by 2030, expanding at a CAGR of 21.94% over the forecast period, according to a new report by Grand View Research, Inc. The healthcare industry is shifting toward the adoption of healthcare IT solutions, … Read more
SAN FRANCISCO, June 22, 2023 /PRNewswire/ — The global operating room equipment market size is expected to reach USD 75.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2023 to 2030. The key factors driving the market growth … Read more
MARLBOROUGH, Mass., June 21, 2023 /PRNewswire/ — AssayQuant® Technologies, Inc. introduces KinSight™ Kinome Profiling Services providing superior results including kinetic insights into selectivity and mechanisms of action for drug discovery. Kinase inhibitors are effective in targeting deregulation mechanisms that drive disease progression, yet only 15% of kinases have FDA-approved inhibitors. AssayQuant’s kinome profiling platform provides … Read more
BRANFORD, Conn., June 21, 2023 /PRNewswire/ — Azitra, Inc. (NYSE American: AZTR) (the “Company”), a biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products, today announced the closing of its initial public offering of 1,500,000 shares of its common stock at a public offering price of … Read more